-
Glofitamab, sold
under the
brand name Columvi, is a
bispecific monoclonal antibody used for the
treatment of
large B-cell lymphoma. It is a bispecific...
- Bi-specific T-cell
engager (BiTE) is a
class of
artificial bispecific monoclonal antibodies that are
investigated for use as anti-cancer drugs. They direct...
- (Bevacizumab) Leukemia/lymphoma lymphoid: CD3 (
Glofitamab, Elranatamab, Mosunetuzumab), CD20 (
Glofitamab Ibritumomab Mosunetuzumab Obinutuzumab Ofatumumab...
-
adult patients with
relapsed or
refractory DLBCL after systemic therapy.
Glofitamab (Columvi) is a
bispecific monoclonal antibody that was
approved for medical...
-
Mosunetuzumab L01FX26
Mirvetuximab soravtansine L01FX27
Epcoritamab L01FX28
Glofitamab L01FX29
Talquetamab L01FY01
Pertuzumab and
trastuzumab L01FY02 Nivolumab...
- (Bevacizumab) Leukemia/lymphoma lymphoid: CD3 (
Glofitamab, Elranatamab, Mosunetuzumab), CD20 (
Glofitamab Ibritumomab Mosunetuzumab Obinutuzumab Ofatumumab...
-
carcinoma Glembatumumab vedotin mab
human GPNMB melanoma,
breast cancer Glofitamab Columvi BsAb
humanized CD20, CD3 Y
diffuse large B-cell
lymphoma Golimumab...
- (INN)
glisoxepide (INN)
globin zinc
insulin injection (INN) Glofil-125
glofitamab (INN)
gloxazone (INN)
gloximonam (INN)
Glucagen glucagon (INN) glucalox...
- amivantamab, tebentafusp, faricimab, teclistamab, mosunetuzumab, epcoritamab,
glofitamab.
Among the bsAb
programs currently under development, the combination...
- Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§
Gemtuzumab ozogamicin Glofitamab Imgatuzumab§
Inotuzumab ozogamicin Labetuzumab§
Lifastuzumab vedotin§...
